Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer

W Wungki Park A Anup Kasi (University of Kansas Medical Center, Kansas City) A Alexander I. Spira (Virginia Cancer Specialists and NEXT Oncology-Virginia, Fairfax) L Luis Paz-Ares Rodríguez (Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid) B Benjamin O. Herzberg (Division of Hematology/Oncology, Columbia University Irving Medical Center, New York) M Meredith S. Pelster (Sarah Cannon Research Institute, Nashville) A Anthony W. Tolcher (NEXT Oncology, San Antonio, TX) Y Yasutoshi Kuboki (Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan) S Shigehisa Kitano (Department of Advanced Medical Development, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo) H Hirokazu Shoji (Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo) J Judy S. Wang (Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota) J Jordan D. Berlin (Division of Hematology and Oncology, Vanderbilt-Ingram Cancer Center, Nashville) A Antoine Hollebecque (Gustave Roussy, Villejuif, France) P Patricia LoRusso (Yale School of Medicine, New Haven, CT) C Christos Fountzilas (Roswell Park Comprehensive Cancer Center, Buffalo, NY) P Philippe A. Cassier (Department of Medical Oncology, Centre Léon Bérard, Lyon, France) T Tomohiro Nishina (Department of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan) D Daisuke Sakai (Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan) C Chiaki Inagaki (Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan) D Daniel Morgensztern (Department of Medicine, Washington University School of Medicine, St. Louis) M Makoto Ueno M Minkyu Jung (Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea) S Sang-We Kim (Asan Medical Center, Seoul, South Korea) P Pasi A. Jänne A Antoine Italiano (Gustave Roussy, Villejuif, France) B Benoît You (Lyon University Hospital, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Lyon University, Lyon, France) T T Macarulla (Medical Oncology Department, Hospital Clinic Barcelona, Translational Oncology in Upper Gastrointestinal Cancer Group, IDIBAPS, Barcelona) H Hisaki Fujii (Astellas Pharma, Northbrook, IL) A Aditya Shetty (Astellas Pharma, Northbrook, IL) Y Ying Lu D Daniel Cui (Astellas Pharma, Northbrook, IL) S Shilpa Kadam (Astellas Pharma, Northbrook, IL) S Stanley C. Gill (Astellas Pharma, Northbrook, IL) J Junko Toyoshima (Astellas Pharma, Northbrook, IL) T Takeshi Saito (Astellas Pharma, Northbrook, IL) J Jonathan W. Goldman

Article Details

Volume / Issue Vol. 394, Issue 14
Published April 09, 2026
Pages 1409-1420
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (36)

W

Wungki Park

A

Anup Kasi

University of Kansas Medical Center, Kansas City

A

Alexander I. Spira

Virginia Cancer Specialists and NEXT Oncology-Virginia, Fairfax

L

Luis Paz-Ares Rodríguez

Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid

B

Benjamin O. Herzberg

Division of Hematology/Oncology, Columbia University Irving Medical Center, New York

M

Meredith S. Pelster

Sarah Cannon Research Institute, Nashville

A

Anthony W. Tolcher

NEXT Oncology, San Antonio, TX

Y

Yasutoshi Kuboki

Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan

S

Shigehisa Kitano

Department of Advanced Medical Development, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo

H

Hirokazu Shoji

Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo

J

Judy S. Wang

Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota

J

Jordan D. Berlin

Division of Hematology and Oncology, Vanderbilt-Ingram Cancer Center, Nashville

A

Antoine Hollebecque

Gustave Roussy, Villejuif, France

P

Patricia LoRusso

Yale School of Medicine, New Haven, CT

C

Christos Fountzilas

Roswell Park Comprehensive Cancer Center, Buffalo, NY

P

Philippe A. Cassier

Department of Medical Oncology, Centre Léon Bérard, Lyon, France

T

Tomohiro Nishina

Department of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan

D

Daisuke Sakai

Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan

C

Chiaki Inagaki

Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan

D

Daniel Morgensztern

Department of Medicine, Washington University School of Medicine, St. Louis

M

Makoto Ueno

M

Minkyu Jung

Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea

S

Sang-We Kim

Asan Medical Center, Seoul, South Korea

P

Pasi A. Jänne

A

Antoine Italiano

Gustave Roussy, Villejuif, France

B

Benoît You

Lyon University Hospital, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Lyon University, Lyon, France

T

T Macarulla

Medical Oncology Department, Hospital Clinic Barcelona, Translational Oncology in Upper Gastrointestinal Cancer Group, IDIBAPS, Barcelona

H

Hisaki Fujii

Astellas Pharma, Northbrook, IL

A

Aditya Shetty

Astellas Pharma, Northbrook, IL

Y

Ying Lu

D

Daniel Cui

Astellas Pharma, Northbrook, IL

S

Shilpa Kadam

Astellas Pharma, Northbrook, IL

S

Stanley C. Gill

Astellas Pharma, Northbrook, IL

J

Junko Toyoshima

Astellas Pharma, Northbrook, IL

T

Takeshi Saito

Astellas Pharma, Northbrook, IL

J

Jonathan W. Goldman